Trends in the management of recurrent respiratory papillomatosis in Japan
Trends in the management of recurrent respiratory papillomatosis in Japan
复制标题
日本复发性呼吸道乳头状瘤病的治疗趋势
DOI：
10.1016/j.anl.2014.10.006
复制
发表时间：
2015
影响因子：
1.7
通讯作者：
Yoshizaki T
中科院分区：
文献类型：
--
作者：
Murono S;Nakanishi Y;Tsuji A;Endo K;Kondo S;Wakisaka N;Yoshida H;Yoshizaki T
复发性呼吸道乳头状瘤病（RRP）在历史上一直是，仍然是一个困难的疾病treat.The本研究的目的是描述目前的做法，在治疗RRP在Japanes.MethodsA问卷被张贴到耳鼻喉科的所有80个中央大学医院在Japanes.ResultsA共56所大学回应了调查。关于手术器械的使用，观察到倾向于激光（50家医院）而不是微型吸切器（16家医院）或冷器械（20家医院）。在50家经常进行激光手术的医院中，二氧化碳（CO2）激光最常用，其次是磷酸钛氧钾（KTP）激光。最受欢迎的辅助治疗是中医药。856所大学医院有使用西多福韦的经验，共涉及28 patients.ConclusionThe本研究表明，目前的趋势，在管理RRP的基础上，在一个地理区域以外的美国和英国的问卷调查第一次。除日本最不流行使用西多福韦外，所有三个地区的治疗趋势基本相似。
ObjectiveRecurrent respiratory papillomatosis (RRP) has historically been and still continues to be a difficult disease to treat. The present study aimed to characterize current practices in the treatment of RRP in Japan.MethodsA questionnaire was posted to the Department of Otolaryngology of all 80 central university hospitals in Japan.ResultsA total of 56 universities responded to the survey. Regarding the use of surgical instruments, a trend toward a preference for lasers (50 hospitals) rather than a microdebrider (16 hospitals) or cold instruments (20 hospitals) was observed. Among the 50 hospitals frequently performing laser surgery, a carbon dioxide (CO2) laser was most commonly used, followed by a potassium-titanyl-phosphate (KTP) laser. The most favored adjuvant therapy was traditional Chinese medicine. Eight of the 56 university hospitals had an experience of using cidofovir, involving a total of 28 patients.ConclusionThe present study demonstrated the current trends in the management of RRP based on a questionnaire survey in a geographical area other than the US and UK for the first time. Treatment trends were generally similar in all three areas except for the least popular use of cidofovir in Japan.